The results showed that ATM- and p53-deficient cells are more sensitive than ATM-deficient cells to olaparib, indicating that p53 regulates the response of ATM‐deficient MCL cells to Olaparib [106]. The gene discussed is TP53; the disease is mantle cell lymphoma.